Utah Medical Products (UTMD) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to 0.97.
- Utah Medical Products' Equity Ratio rose 123.87% to 0.97 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.97, marking a year-over-year increase of 123.87%. This contributed to the annual value of 0.96 for FY2024, which is 116.52% up from last year.
- As of Q3 2025, Utah Medical Products' Equity Ratio stood at 0.97, which was up 123.87% from 0.97 recorded in Q2 2025.
- In the past 5 years, Utah Medical Products' Equity Ratio registered a high of 0.97 during Q2 2025, and its lowest value of 0.91 during Q1 2022.
- Its 5-year average for Equity Ratio is 0.94, with a median of 0.93 in 2023.
- As far as peak fluctuations go, Utah Medical Products' Equity Ratio plummeted by 61.91% in 2022, and later soared by 316.42% in 2023.
- Quarter analysis of 5 years shows Utah Medical Products' Equity Ratio stood at 0.93 in 2021, then decreased by 0.45% to 0.92 in 2022, then rose by 2.7% to 0.95 in 2023, then grew by 1.17% to 0.96 in 2024, then increased by 1.17% to 0.97 in 2025.
- Its Equity Ratio was 0.97 in Q3 2025, compared to 0.97 in Q2 2025 and 0.96 in Q1 2025.